Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

  • Quoted phrase not found.
1.

Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.

Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM.

Heart. 2015 Feb;101(4):294-301. doi: 10.1136/heartjnl-2014-306387. Epub 2014 Oct 28.

2.

Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life.

Weber R, Kantor P, Chitayat D, Friedberg MK, Golding F, Mertens L, Nield LE, Ryan G, Seed M, Yoo SJ, Manlhiot C, Jaeggi E.

JACC Heart Fail. 2014 Aug;2(4):403-11. doi: 10.1016/j.jchf.2014.02.010. Epub 2014 Jul 9.

PMID:
25023818
3.

Factors predicting long-term mortality in patients with hypertrophic cardiomyopathy.

Bostan C, Sinan UY, Canbolat P, Abaci O, Munipoglu SK, Kucukoglu S.

Echocardiography. 2014 Oct;31(9):1056-61. doi: 10.1111/echo.12537. Epub 2014 Feb 8.

PMID:
24506463
4.

Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.

Forsey J, Benson L, Rozenblyum E, Friedberg MK, Mertens L.

J Am Soc Echocardiogr. 2014 Feb;27(2):215-21. doi: 10.1016/j.echo.2013.10.012. Epub 2013 Dec 8.

PMID:
24325958
5.

Nonobstructive hypertrophic cardiomyopathy with left ventricular aneurysm: the role of cardiac magnetic resonance.

Luni FK, Moza A, Sheikh M, Coker MF, Chaganti SK, Lewis TJ, Kanjwal Y.

Tex Heart Inst J. 2013;40(4):465-7.

6.

Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.

Anastasakis A, Theopistou A, Rigopoulos A, Kotsiopoulou C, Georgopoulos S, Fragakis K, Sevdalis E, Stefanadis C.

Hellenic J Cardiol. 2013 Jul-Aug;54(4):281-8.

7.

Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.

Meyer T, Pankuweit S, Richter A, Maisch B, Ruppert V.

Gene. 2013 Sep 15;527(1):416-20. doi: 10.1016/j.gene.2013.06.025. Epub 2013 Jun 29.

PMID:
23816408
8.

Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.

Núñez L, Gimeno-Blanes JR, Rodríguez-García MI, Monserrat L, Zorio E, Coats C, McGregor CG, Hernandez del Rincón JP, Castro-Beiras A, Hermida-Prieto M.

Circ J. 2013;77(9):2358-65. Epub 2013 Jun 19.

9.

Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.

Kazmierczak K, Paulino EC, Huang W, Muthu P, Liang J, Yuan CC, Rojas AI, Hare JM, Szczesna-Cordary D.

Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H575-89. doi: 10.1152/ajpheart.00107.2013. Epub 2013 Jun 7.

10.

A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations.

Lopes LR, Rahman MS, Elliott PM.

Heart. 2013 Dec;99(24):1800-11. doi: 10.1136/heartjnl-2013-303939. Epub 2013 May 14. Review.

PMID:
23674365
11.

The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.

Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):91-100. doi: 10.1161/CIRCEP.112.975268. Epub 2012 Dec 29.

12.

Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.

Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A, Skovby F, Køber L, Bundgaard H.

Circulation. 2013 Jan 1;127(1):48-54. doi: 10.1161/CIRCULATIONAHA.111.090514. Epub 2012 Nov 28.

13.

A case of compound mutations in the MYBPC3 gene associated with biventricular hypertrophy and neonatal death.

Marziliano N, Merlini PA, Vignati G, Orsini F, Motta V, Bandiera L, Intrieri M, Veronese S.

Neonatology. 2012;102(4):254-8. doi: 10.1159/000339847. Epub 2012 Aug 17.

PMID:
22907696
14.

High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.

Rani DS, Nallari P, Priyamvada S, Narasimhan C, Singh L, Thangaraj K.

BMC Med Genet. 2012 Aug 10;13:69. doi: 10.1186/1471-2350-13-69.

15.

Atrioventricular canal defect in patients with RASopathies.

Digilio MC, Romana Lepri F, Dentici ML, Henderson A, Baban A, Roberti MC, Capolino R, Versacci P, Surace C, Angioni A, Tartaglia M, Marino B, Dallapiccola B.

Eur J Hum Genet. 2013 Feb;21(2):200-4. doi: 10.1038/ejhg.2012.145. Epub 2012 Jul 11.

16.

Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers.

Yiu KH, Atsma DE, Delgado V, Ng AC, Witkowski TG, Ewe SH, Auger D, Holman ER, van Mil AM, Breuning MH, Tse HF, Bax JJ, Schalij MJ, Marsan NA.

PLoS One. 2012;7(5):e36115. doi: 10.1371/journal.pone.0036115. Epub 2012 May 4.

17.

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ.

Heart. 2012 Apr;98(8):631-6. doi: 10.1136/heartjnl-2011-300924.

PMID:
22505462
18.

Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.

Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ.

Circ Cardiovasc Genet. 2012 Apr 1;5(2):156-66. doi: 10.1161/CIRCGENETICS.111.960831. Epub 2012 Jan 20.

19.

Cardiac Troponin T (TNNT2) mutations are less prevalent in Indian hypertrophic cardiomyopathy patients.

Rani DS, Nallari P, Dhandapany PS, Tamilarasi S, Shah A, Archana V, AshokKumar M, Narasimhan C, Singh L, Thangaraj K.

DNA Cell Biol. 2012 Apr;31(4):616-24. doi: 10.1089/dna.2011.1366. Epub 2011 Oct 21.

PMID:
22017532
20.

Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.

Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.

J Am Coll Cardiol. 2011 Aug 16;58(8):839-48. doi: 10.1016/j.jacc.2011.05.018.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk